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2015 AGA Institute Council
Section Research Mentor
Awardeesach year, Digestive Disease Week® brings togetherEthe best clinical, translational, and basic science in
the ﬁeld. It is also an opportunity for many trainees and
young investigators to present their work, receive advice
from senior investigators, and build their professional net-
works. During the 2015 annual meeting, the American
Gastroenterological Association (AGA) recognized one mem-
ber each from six AGA Institute Council sections who have
committed themselves to training these young investigators
and have a demonstrated track record of outstanding
research mentorship. The awardees for each section follow.Esophageal, Gastric,
and Duodenal
Disorders Section
(EGD): David Y.
Graham, MD
David Graham is a staff physi-
cian at the Michael E. DeBakey VA
Medical Center, and a professor in
the departments of Medicine and
Molecular Virology and Microbi-
ology at Baylor College of Medicine
in Houston, Texas. He received his
undergraduate degree from the University of Notre Dame in
SouthBend, Indiana, andhisMDdegreewithhonor fromBaylor
University College of Medicine in 1966. He is board certiﬁed inAGA President Michael Camilleri, MD, AGAF (center),
gastroenterology and Motility section from section chair Pa
MD, PhD, AGAF (right). Photo courtesy of Oscar & Associates
CelluMedicine and Gastroenterology. Dr. Graham is the author of
more than 900 scientiﬁc papers, several books, and 100
chapters in medical textbooks. He is an Institute for Scientiﬁc
Information (ISI) Highly Cited Researcher in Clinical Medicine.
He has trained more than 125 foreign physician-scientists and
more than 200 U.S. gastroenterology fellows. He has patents in
the development of diagnostic tests for Helicobacter pylori
infection, the cause of peptic ulcer and gastric cancer, and in
vaccine development for Norwalk virus infection, the most
common cause of food borne and cruise ship–associated diar-
rhea. His research currently focuses on infections and the in-
testine, and includes studieswithHelicobacter pylori, rotavirus,
Norwalk virus, and Mycobacterium paratuberculosis.Gastrointestinal
Oncology Section
(GIONC): Stephen J.
Meltzer, MD
Stephen Meltzer is the Harry
and Betty Myerberg-Thomas R.
Hendrix Professor of Medicine and
Oncology at the Johns Hopkins
University School of Medicine,
Gastroenterology and Hepatology
Division. He is also the American
Cancer Society Clinical Research
Professor and the director of the
Gastrointestinal Early Detection Biomarkers Laboratory at
Johns Hopkins. His research focuses on biomechanisms and
biomarker development in premalignant diseases of the
esophagus, stomach, and colon. After receiving his degree in
medicine from the State University of New York at Buffalo’s
medical school, Dr Meltzer did his internal medicinereceives the Research Mentor Award for the Neuro-
nkaj J. Pasricha, MD (left), and vice chair Satish S.C. Rao,
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and his internal medicine residency at the University of
Texas Medical Branch in Galveston, Texas. He did a split
gastrointestinal fellowship at the University of Colorado in
Denver and at Lenox Hill Hospital in New York. He then
underwent molecular biology postdoctoral training at the
University of California–Los Angeles Center for the Health
Sciences in 1985–1987. Before joining the faculty at Johns
Hopkins in 2006, he was a professor of medicine and
pharmacology as well as founder and head of the Aero-
digestive Cancer/Biomarker Program, and director of Core
Sciences in the Cancer Center at the University of Maryland
School of Medicine. He is an associate editor of Cancer
Research and a member of the editorial boards of several
other scientiﬁc journals.Growth, Development,
and Child Health
Section (GDCH):
Richard J. Grand, MD
Richard Grand received his AB
degree from Harvard College
(magna cum laude) and his MD
degree from the New York Uni-
versity School of Medicine. A
pediatrics internship at Bellevue
Hospital in New York City and a
residency at Boston Children’s
Hospital (BCH) preceded research fellowships at the Na-
tional Institutes of Health (NIH), BCH, the Massachusetts
Institute of Technology, and Massachusetts General Hospi-
tal. He has served as gastrointestinal consultant to the Cystic
Fibrosis Center at BCH, is director emeritus of the Center for
Inﬂammatory Bowel Disease in the Division of Gastroen-
terology and Nutrition at BCH, and is program director
emeritus of the Clinical and Translational Study Unit
(formerly the GCRC) also at BCH. He received his ﬁrst NIH
R01 grant in 1971 for studies of gastrointestinal develop-
ment and molecular regulation of intestinal genes, particu-
larly that for lactase-phlorizin hydrolase. In 1999, he
received an NIH MERIT Award, and it remained his major
source of laboratory support until 2009. He has also been
funded by the Crohn’s and Colitis Foundation of America,
the Cystic Fibrosis Foundation, and other NIH grants. He has
served as program director of an NIH research training
grant, and as associate director of the NIH Digestive Disease
Core Center at New England Medical Center and Tufts
University School of Medicine (both 1984–2001); core di-
rector of the Human Nutrition Core at the Boston Obesity
Nutrition Research Center (1997–2001); and acting director
of the Boston Obesity Nutrition Research Center
(1997–1998). He has trained over 100 pediatric gastroen-
terology fellows and an additional 100 medical students in
basic and clinical research. He has previously received the
William Silen Mentoring Award from Harvard Medical
School and the Henry D. Janowitz, MD, Lifetime Achievement
Award from the Crohn’s and Colitis Foundation of America.Intestinal Disorders
Section (ID): Jerrold R.
Turner, MD, PhD, AGAF
Jerrold (Jerry) Turner is the
Sara and Harold Lincoln Thompson
Professor of Pathology and Medi-
cine and the associate chair of the
Department of Pathology at the
University of Chicago and editor-in
chief of Cellular and Molecular
Gastroenterology and Hepatology.
He is an actively practicing gastrointestinal surgical
pathologist and teacher with numerous postdoctoral fel-
lows, graduate students, and undergraduate students in his
laboratory, and he has made regular contributions to lead-
ing textbooks of pathology, surgical pathology, and gastro-
enterology. He has also been active in promoting career
development beyond his institution by means of lectures,
grant reviews, and informal interactions with junior faculty
and trainees. His research program, which has been
continuously funded by the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) since 1994 and
has also been supported by the Department of Defense,
Crohn’s and Colitis Foundation of America, and Broad
Medical Research Foundation, is focused on intestinal
epithelial biology, with particular emphasis on tight junction
regulation and inﬂammatory bowel disease. His group takes
a multidisciplinary approach that integrates cell biology,
transport physiology, electrophysiology, structural biology,
molecular biology, and mucosal immunology, making the
laboratory a rich training environment.Neurogastroenterology
and Motility Section
(NGM): Michael
Camilleri, MD, AGAF
Michael Camilleri is a consul-
tant in the Division of Gastroen-
terology and Hepatology in the
Department of Internal Medicine
at the Mayo Clinic. He was recog-
nized with the Atherton and
Winifred W. Bean Professorship in 2001 and as a Mayo
Distinguished Investigator in 2008. He currently serves as
executive dean for the Department of Development. He
holds the ranks of professor of medicine, pharmacology, and
physiology at the Mayo Clinic College of Medicine. He
received his MD degree from University of Malta Medical
School and completed his residency at St. Luke’s University
Hospital in Malta. He pursued fellowships in research and
internal medicine and gastroenterology at Hammersmith
Hospital at the University of London, United Kingdom. He
completed fellowships at the Mayo Graduate School in both
research and clinical studies in gastroenterology.
Throughout his training and career, he has received
numerous awards and honors, including the 2012 Ismar
July 2015 Commentary 345Boas Medal from the German Society of Digestive and
Metabolic Disease, the 2012 American Gastroenterological
Association Distinguished Mentor Award, the Janssen
Research Award, and the Joseph B. Kirsner Award from the
American Gastroenterological Association, and he is listed in
“Best Doctors in America” for gastroenterology and gastro-
intestinal motility. He also participates in educational and
mentorship activities at the Mayo Clinic and has mentored
many national and international postdoctoral fellows and
scientists. He is a faculty member in the Clinical Research
Training Program and has full faculty privileges in Clinical
and Translational Science at the Mayo Graduate School. He
maintains an active clinical practice in gastroenterology at
the Mayo Clinic, specializing in gastroenterology motility
disorders, gastroparesis, and functional gastrointestinal
disorders. He is the current president of the American
Gastroenterological Association.Obesity, Metabolism,
and Nutrition Section
(OMN): Samuel Klein,
MD
Samuel Klein is the William H.
Danforth Professor of Medicine,
director of the Center for Human
Nutrition, director of the Center for
Applied Research Sciences, chief of
the Division of Geriatrics andNutritional Sciences, and medical director of the Weight
Management Program at theWashington University School of
Medicine in St. Louis, Missouri. He received his MD degree
from Temple University Medical School in Philadelphia, and
an MS degree in nutritional biochemistry and metabolism
from the Massachusetts Institute of Technology. He has
received numerous awards for his research, including the
American Gastroenterological Association (AGA) Miles and
Shirley Fiterman Foundation Award in Nutrition, the AGA
Masters Award for Outstanding Achievement in Basic or
Clinical Research in Digestive Sciences, the Academy of Sci-
ence–St. Louis Award forOutstandingAchievement in Science,
and the Obesity Society TOPS Research Achievement Award.
His research activities are focused on understanding the
mechanisms responsible formetabolic dysfunction associated
with obesity, particularly nonalcoholic fatty liver disease, and
the therapeutic effects ofweight loss, and he also is committed
to training young investigators and clinicians in nutrition and
obesity. He has developed an outstanding environment for
training young clinical investigators, who can obtain
comprehensive experience in a variety of aspects of clinical
investigation through his program, and has provided
mentorship to 31postdoctoral trainees and junior faculty (MD
and PhD) in clinical obesity and metabolism research.© 2015 The Authors. Published by Elsevier Inc. on behalf of the AGA
Institute. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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